Search

everythinglearnresearchcommunity

for

Search:↓

Androgens significantly affect female hair loss, and hormonal treatments may help.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

Women under 55 with hair loss (AGA) may have a higher risk of heart disease (CAD).

Hair loss reduces hair thickness and coverage, but drug treatments mainly revive dormant hairs rather than reverse thinning; patients often undervalue their hair loss severity.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

FPHL affects hair density and diameter, causing visible hair loss in older women.

Women with androgenetic alopecia have lower zinc and iron levels.

Certain gene variations may protect against skin issues and oxidative stress in women with PCOS.

Dermoscopy effectively diagnoses and evaluates female hair loss treatment.

Women losing hair might have lower levels of vitamin D.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Hair loss in middle-aged women is often linked to insulin resistance and a family history of hair loss, particularly from their fathers.

The study concluded that female pattern hair loss is linked to psychological distress and is hard to diagnose and treat, with its causes still not fully understood.

Female hair loss is often hereditary and can be treated with medication, hair transplants, and lasers.

Higher concentration of botulinum toxin A is safe and effective for treating hair loss in men and women.

Dopaminergic therapy in Parkinson's disease patients is linked to increased hair loss.

Some psychiatric drugs can cause severe hair loss, especially valproic acid, and it's more likely in women or those with thyroid issues or past hair loss.

"Male-pattern" hair loss is common in women, especially after menopause, and doesn't always mean there's a problem with hormone balance.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

The modified hair loss classification is more detailed but less user-friendly.

New dermoscopic criteria accurately diagnose and grade the severity of hair loss in androgenetic alopecia.

Stem cell treatment improved life quality and sexual function in women with hair loss.

Female pattern baldness may indicate a higher risk of coronary artery disease.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Androgenetic alopecia is more common in Indian men than women, and family history is a strong risk factor.

Smoking and drinking worsened hair loss in men with genetic hair loss, while eating and sleeping habits didn't; genetics played a bigger role than environment in hair loss.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Low iron levels are linked to hair loss in women.

Platelet-rich plasma injections significantly improve hair density and thickness in both male and female pattern hair loss, especially in early stages.

Androgenetic alopecia is common in South-West Nigeria, affecting more men than women, with stress worsening the condition.